cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity.
Nature. 2020 Aug;584(7822):624-629. doi: 10.1038/s41586-020-2611-3. Epub 2020 Aug 12.
Nature. 2020.
PMID: 32788723
Free PMC article.